Taq patent battle a step nearer to trial
This article was originally published in Clinica
Executive Summary
The Taq patent battle between US diagnostic ingredient manufacturer Promega and Swiss pharmaceutical company Roche has come a step nearer to trial. A federal district court in San Francisco has concluded that Cetus obtained the patent, now held by Roche, by withholding material information from the patent office. However, it did not go so far as to say Cetus had intended to deceive, choosing instead to conclude the company had exhibited gross negligence.